Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia
Clinical trial NCT00366418 · COMPLETED
Trial details
- NCT number
- NCT00366418
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-10
- Primary completion
- 2009-06-11
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.